Training: Webcasts
Prescription Drug Costs: Can Increased Competition Restrain Prices? |
 |
06/14/18 Online |
BEYOND THE BELTWAY: HEALTH WEBINARS FOR JOURNALISTS
There has been growing momentum among policymakers to address rising prescription drug prices. One solution is leveraging market forces to bring down costs by increasing competition through generics and biosimilars. During this webinar panelists will discuss the main opportunities and challenges of the generic and biosimilar market, how past administrations have approached this issue, and how different stakeholders, including consumers, are impacted.
Thursday, June 14, 2018
1 p.m. - 2:15 p.m. ET
Speakers:
-
Sameer Awsare, M.D., associate executive director, The Permanente Medical Group
-
Dora Hughes, M.D., senior policy advisor, Sidley Austin LLP
-
Robert Langreth, science and health reporter, Bloomberg News
-
Andrew Barnhill, J.D., director of federal policy, GlaxoSmithKline
-
Moderator: Mary Ella Payne, MSPH, R.N., acting president and chief executive officer, Alliance for Health Policy
*Please note that panels are subject to change due to the addition of speakers*